Denosumab for Breast Cancer With Bone Mets

NCT01952054 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Denosumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]